Cargando…

Characterizing white matter alterations subject to clinical laterality in drug‐naïve de novo Parkinson's disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by a range of motor and nonmotor symptoms, often with the motor dysfunction initiated unilaterally. Knowledge regarding disease‐related alterations in white matter pathways can effectively help improve th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yiming, Peters, Terry M., Khan, Ali R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410564/ https://www.ncbi.nlm.nih.gov/pubmed/34106502 http://dx.doi.org/10.1002/hbm.25558

Ejemplares similares

White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
por: Mojtahed Zadeh, Mahtab, et al.
Publicado: (2018)

White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness
por: Ashraf-Ganjouei, Amir, et al.
Publicado: (2019)

Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
por: Ashraf-Ganjouei, Amir, et al.
Publicado: (2018)

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022)

White matter alterations in drug-naïve children with Tourette syndrome and obsessive-compulsive disorder
por: Bharti, Komal, et al.
Publicado: (2022)

Alterations in White Matter Network and Microstructural Integrity Differentiate Parkinson’s Disease Patients and Healthy Subjects
por: Koirala, Nabin, et al.
Publicado: (2019)

Characterization of white matter alterations using diffusion kurtosis imaging in patients with amyotrophic lateral sclerosis
por: Anand, Tanushka, et al.
Publicado: (2023)

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
por: Grashorn, Wiebke, et al.
Publicado: (2019)

Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease
por: Orso, Beatrice, et al.
Publicado: (2021)

Association between gray/white matter contrast and white matter microstructural alterations in medication-naïve obsessive–compulsive disorder
por: Niu, Qihui, et al.
Publicado: (2022)

Alteration in Asymmetry of White Matter Network of Parkinson's Disease
por: Chen, Aihong, et al.
Publicado: (2022)

Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients
por: Assogna, Francesca, et al.
Publicado: (2018)

Structural Brain Network Alteration and its Correlation With Structural Impairments in Patients With Depression in de novo and Drug-Naïve Parkinson's Disease
por: Gou, Lubin, et al.
Publicado: (2018)

Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson's disease
por: Joy, Sanju P., et al.
Publicado: (2014)

Altered single‐subject gray matter structural networks in drug‐naïve attention deficit hyperactivity disorder children
por: Chen, Ying, et al.
Publicado: (2021)

Cortico-basal white matter alterations occurring in Parkinson’s disease
por: Isaacs, Bethany. R., et al.
Publicado: (2019)

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
por: Dadar, Mahsa, et al.
Publicado: (2018)

White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy
por: Rektor, Ivan, et al.
Publicado: (2018)

White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder()
por: Yip, Sarah W., et al.
Publicado: (2013)

White Matter Tracts in Patients with Temporal Lobe Epilepsy: Pre- and Postoperative Assessment
por: Salehi, Fateme, et al.
Publicado: (2017)

White matter alterations and tract lateralization in children with dyslexia and isolated spelling deficits
por: Banfi, Chiara, et al.
Publicado: (2018)

Gray and White Matter Volumes and Cognitive Dysfunction in Drug-Naïve Newly Diagnosed Pediatric Epilepsy
por: Lee, Jung Hwa, et al.
Publicado: (2015)

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia
por: Lang, Xiao-E, et al.
Publicado: (2018)

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson’s Disease
por: Surova, Yulia, et al.
Publicado: (2016)

White matter changes in Parkinson’s disease
por: Yang, Kai, et al.
Publicado: (2023)

Altered Intra- and Inter-Network Connectivity in Drug-Naïve Patients With Early Parkinson’s Disease
por: Zeng, Weiqi, et al.
Publicado: (2022)

The Influence of Myelin Oligodendrocyte Glycoprotein on White Matter Abnormalities in Different Onset Age of Drug-Naïve Depression
por: Wu, Feng, et al.
Publicado: (2018)

The Shared and Distinct White Matter Networks Between Drug-Naive Patients With Obsessive-Compulsive Disorder and Schizophrenia
por: Qin, Jiaolong, et al.
Publicado: (2019)

Desynchronized white matter function and structure in drug-naive first-episode major depressive disorder patients
por: Guo, Qinger, et al.
Publicado: (2023)

A longitudinal fixel-based analysis of white matter alterations in patients with Parkinson's disease
por: Rau, Yi-Ai, et al.
Publicado: (2019)

Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson’s disease
por: Andica, Christina, et al.
Publicado: (2021)

Sleep structure and related clinical characteristics in drug-naïve Parkinson's disease with subjectively different sleep quality
por: Jiang, Yinyin, et al.
Publicado: (2023)

White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study
por: Lei, Wei, et al.
Publicado: (2015)

Altered cerebellum functional network on newly diagnosed drug-naïve Parkinson’s disease patients with anxiety
por: Wang, Yirong, et al.
Publicado: (2021)

Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson’s Disease: A Meta-Analysis
por: Li, Dun-Hui, et al.
Publicado: (2015)

Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson’s disease patients
por: Meoni, Gaia, et al.
Publicado: (2022)

PM475. White matter abnormalities and their associations with clinical symptoms in first episode and drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

Suicidal Ideation Is Associated With Reduced Functional Connectivity and White Matter Integrity in Drug-Naïve Patients With Major Depression
por: Reis, Joana Vanessa, et al.
Publicado: (2022)

Multiparametric characterization of white matter alterations in early stage Huntington disease
por: Adanyeguh, Isaac M., et al.
Publicado: (2021)

Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage
por: Papuć, Ewa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r2ehd4fm966pp9m4jjpekhghv5